The store will not work correctly when cookies are disabled.
1-(3-Methoxybenzoyl)-5-nitro-1H-indazole-3-carboxylic Acid ethyl ester
ID: ALA2409457
PubChem CID: 71818829
Max Phase: Preclinical
Molecular Formula: C18H15N3O6
Molecular Weight: 369.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1nn(C(=O)c2cccc(OC)c2)c2ccc([N+](=O)[O-])cc12
Standard InChI: InChI=1S/C18H15N3O6/c1-3-27-18(23)16-14-10-12(21(24)25)7-8-15(14)20(19-16)17(22)11-5-4-6-13(9-11)26-2/h4-10H,3H2,1-2H3
Standard InChI Key: SIYHDAGPPJTNHW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
16.2640 -26.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2628 -27.1265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9709 -27.5354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9691 -25.8981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6777 -26.3033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6780 -27.1265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4592 -27.3834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9447 -26.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -26.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4456 -28.1990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7306 -28.5946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1457 -28.6204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1286 -29.4362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8279 -29.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5439 -29.4619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5563 -28.6406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8563 -28.2229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8345 -25.3229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6508 -25.2838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0927 -25.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3926 -24.6355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5555 -25.8987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8479 -26.3075 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5553 -25.0815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9090 -25.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2699 -28.2424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9715 -28.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
22 23 2 0
22 24 1 0
1 22 1 0
20 25 1 0
16 26 1 0
26 27 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 369.33 | Molecular Weight (Monoisotopic): 369.0961 | AlogP: 2.82 | #Rotatable Bonds: 5 |
Polar Surface Area: 113.56 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.80 | CX LogD: 2.80 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.39 | Np Likeness Score: -1.50 |
References
1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670] [10.1021/jm400742j] |